Kapila K Anand Insider Profile
4 Followers
Kapila K Anand, Director at Elanco Animal Health, holds 111.85K shares in Elanco Animal Health (Ticker: ELAN), holds 14.68K shares in Omega Healthcare (Ticker: OHI), holds 0.00 shares in Extended Stay America (Ticker: STAY).
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+9.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kapila K Anand holds in companies
Most Profitable Insider Trade
Stock:
Extended Stay America
(STAY)
(STAY)
Rating:Informative Buy
Date:Mar 09, 2020 - Mar 09, 2021
Return:+90.50%
The most profitable trade made by Kapila K Anand
Kapila K Anand's Trading History
Elanco Animal Health
May 26, 2026
Director
Uninformative Buy
―
$2.48M
Extended Stay America
Jun 17, 2021
―
Informative Sell
796.89K
$0.00
Omega Healthcare
Nov 15, 2021
Director
Informative Buy
28.31K
$670.99K
List of latest transactions for each holding click on a transaction to see Kapila K Anand's performance on stock
You May Also Like
Kapila K Anand insider profile FAQ
What is the percentage of profitable transactions made by Kapila K Anand?
The percentage of profitable transactions made by Kapila K Anand is 60%.
What is the average return per transaction made by Kapila K Anand?
The average return per transaction made by Kapila K Anand is 9.40%.
What stocks does Kapila K Anand hold?
Kapila K Anand holds: ELAN, STAY, OHI stocks.
What was Kapila K Anand’s latest transaction?
Kapila K Anand latest transaction was an Uninformative Buy of ―.
What was Kapila K Anand's most profitable transaction?
Kapila K Anand’s most profitable transaction was an Informative Buy of STAY stock on March 9, 2020. The return on the trade was 90.50%.
What is Kapila K Anand's role in Elanco Animal Health?
Kapila K Anand's role in Elanco Animal Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.